Skip to main content
CGON logo

CG Oncology, Inc.

CGONNASDAQHealthcareBiotechnology

$61.71Today:- (-)1Y +49.07%

As of Oct 23, 2026 close

Market cap
$5.44B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$35.80$80.97
Volume (live)
-
Avg. volume (3M)
1.04M

CG Oncology (CGON) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), CG Oncology used $132.35M of cash in operating activities and spent $134.00K on capital expenditures. That left free cash flow of −$132.48M.

CG Oncology Cash Flow Statement Analysis

Values in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for CG Oncology, Inc. (CGON) - Annual data in billions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Operating Activities
Net Income-0.16-0.09-0.05-0.04-0.01
Depreciation & Amortization0.000.000.000.000.00
Stock Based Compensation0.030.010.000.000.00
Change in Working Capital0.000.000.000.000.00
Change in Accounts Receivable0.000.000.000.000.00
Change in Inventory0.000.000.000.000.00
Change in Accounts Payable0.000.000.000.000.00
Change in Other Working Capital0.00-0.010.000.000.00
Other Operating Activities0.00-0.010.000.000.00
Net Cash from Operating Activities-0.13-0.08-0.05-0.03-0.01
Investing Activities
Capital Expenditures0.000.000.000.000.00
Acquisitions-0.020.000.000.000.00
Purchases of Investments-1.07-1.05-0.52-0.060.00
Sales/Maturities of Investments0.840.750.400.000.00
Net Cash from Investing Activities-0.25-0.30-0.12-0.060.00
Financing Activities
Debt Repayment0.000.00-0.020.000.02
Common Stock Issued0.150.630.000.000.00
Other Financing Activities0.000.000.000.120.00
Net Cash from Financing Activities0.150.630.090.120.02
Summary
Net Change in Cash-0.220.25-0.080.030.00
Cash at Beginning of Period0.260.010.090.050.05
Cash at End of Period0.030.260.010.090.05
Free Cash Flow-0.13-0.08-0.05-0.03-0.01
Supplemental Disclosures
Interest Paid--0.000.000.00

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About CG Oncology Cash Flow

What is CG Oncology's free cash flow?

CG Oncology had negative free cash flow of $132.48M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$132.35M minus $134.00K of capital expenditures.

How much does CG Oncology spend on capital expenditures?

CG Oncology spent $134.00K on capital expenditures in fiscal 2025, compared with $234.00K a year earlier.

Does CG Oncology pay dividends or buy back shares?

CG Oncology's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition